ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for PHARMAESSENTIA USA CORPORATION · Biopharmaceutical company that develops treatments for myeloproliferative neoplasms, more

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $10,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Medicare/Medicaid

Issues related to implementation of the Inflation Reduction Act (IRA, P.L. 117-169).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.